The Clinical Pharmacology Training Program at Johns Hopkins is designed to train highly-qualified physicians and pharmacists to become independent clinical investigators applying the tools of clinical pharmacology to advance drugs from the laboratory to the clinical treatment and prevention of disease in people. This program addresses a critical shortage of well-trained clinician-scientists who conduct hands-on studies in humans, particularly in the area of clinical pharmacology. The program is centered in the Division of Clinical Pharmacology, which is jointly within the Department of Medicine and the Department of Pharmacology and Molecular Sciences, in the School of Medicine. This venue is ideal for conducting research that translates basic molecular discoveries into clinical trials. The training program takes about four years to complete and includes a core curriculum in clinical pharmacology (coursework, conferences, experiential rotations, and research) as well as matriculation in the PhD track of the Graduate Training Program in Clinical Investigation in the School of Public Health. In keeping with the collective expertise of the Division faculty, research commonly focuses on anti-infective drugs, and has been expanded to include oncology, pediatrics, pharmacoepidemiology, and obstetrics and gynecology, among other areas. Each trainee has a mentoring team who oversees the fellow's progress in the principles and analytical disciplines of clinical pharmacology, thesis research, and professional development. Participating faculty are carefully chosen and committed to playing a critical mentoring role for the fellows. Although there are no clinical care responsibilities in the program apart from clinical research, fellows may complete a concurrent clinical subspecialty fellowship. The program solicits and receives the regular advice of an Advisory Board comprised of distinguished translational- or clinician-scientists and outstanding clinical pharmacology educators from within and outside of Johns Hopkins. After completion of this rigorous, comprehensive, and nurturing program, most graduates have achieved board eligibility in Clinical Pharmacology, board eligibility in a medical sub-specialty clinical area (MDs), and a PhD in Clinical Investigation. Graduates have the skills and knowledge to step directly into an independent research careers, nearly all as Assistant Professors, at the interface of basic and clinical pharmacology.

Public Health Relevance

This program trains physicians and pharmacists in the principles and practice of Clinical Pharmacology, a branch of science that focuses on the study of drugs in humans and that brings basic lab discoveries into clinical practice. In a three to four year program, trainees will have rigorous in-class education and will conduct clinical studies of drugs in humans.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Okita, Richard T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Shah, Mirat; Nunes, Maria Raquel; Stearns, Vered (2018) CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer? Oncology (Williston Park) 32:216-22
Ippolito, Matthew M; Huang, Liusheng; Siame, Mwiche et al. (2018) Semi-quantitative measurement of the antimalarial lumefantrine from untreated dried blood spots using LC-MS/MS. J Pharm Biomed Anal 155:241-246
Jackson, Sadhana; Weingart, Jon; Nduom, Edjah K et al. (2018) The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma. Fluids Barriers CNS 15:2
Garcia-Prats, A J; Svensson, E M; Weld, E D et al. (2018) Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children. Int J Tuberc Lung Dis 22:15-23
Weld, Ethel D; Dooley, Kelly E (2018) State-of-the-Art Review of HIV-TB Coinfection in Special Populations. Clin Pharmacol Ther 104:1098-1109
Ippolito, Matthew M; Denny, Joshua E; Langelier, Charles et al. (2018) Malaria and the Microbiome: A Systematic Review. Clin Infect Dis 67:1831-1839
Ippolito, Matthew M; Kamavu, Luc K; Kabuya, Jean-Bertin et al. (2018) Risk Factors for Mortality in Children Hospitalized with Severe Malaria in Northern Zambia: A Retrospective Case-Control Study. Am J Trop Med Hyg 98:1699-1704
Eke, Ahizechukwu C; McCormack, Shelley A; Best, Brookie M et al. (2018) Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum. J Clin Pharmacol :
Ippolito, Matthew M; Jacobson, Jeffrey M; Lederman, Michael M et al. (2018) Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-chloroquine. Clin Infect Dis 67:1617-1620
Seddon, J A; Weld, E D; Schaaf, H S et al. (2018) Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done? Int J Tuberc Lung Dis 22:24-33

Showing the most recent 10 out of 62 publications